Gaucher

n.

高雪氏症；

Parkinsonism among Gaucher disease carriers.
The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease.
Enzyme replacement therapy in Gaucher's disease: large-scale purification of glucocerebrosidase suitable for human administration.
Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.
Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant...
METABOLISM OF GLUCOCEREBROSIDES. II. EVIDENCE OF AN ENZYMATIC DEFICIENCY IN GAUCHER'S DISEASE
Therapeutic response to intravenous infusions of glucocerebrosidase in a patient with Gaucher disease
Cox, T. et al. Novel oral treatment of Gaucher's disease with N-butyldeoaxynojirimycin (OGT918) to decrease substrate biosynthesis...
Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease
Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report f...